In a transfer colitis mouse model, which is achieved by injection of anti-CEA CAR CD4+ Teffs, suppressive effects and inhibitory effects on abdominal accumulation of the anti-CAR CD4+ Teffs were achieved by treatment with CEA-specific CAR Tregs. This evidence concerns the gene CEACAM5 and colitis.